These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15687469)

  • 1. There might be gold at the end of the rainbow.
    Chilton L
    Pediatrics; 2005 Feb; 115(2):514; author reply 514-5. PubMed ID: 15687469
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for a science of community genetics.
    Modell B
    Birth Defects Orig Artic Ser; 1992; 28(3):131-41. PubMed ID: 1489951
    [No Abstract]   [Full Text] [Related]  

  • 3. Should all pregnant patients be offered prenatal diagnosis regardless of age?
    St Amant M; Elkins TE; Brown D; Pastorek JG
    Obstet Gynecol; 1993 Aug; 82(2):315-6. PubMed ID: 8336885
    [No Abstract]   [Full Text] [Related]  

  • 4. Policy analysis for prenatal genetic diagnosis.
    Thompson M; Milunsky A
    Public Policy; 1979; 27(1):25-48. PubMed ID: 10308835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EuroGentest: DNA-based testing for heritable disorders in Europe.
    Javaher P; Kaariainen H; Kristoffersson U; Nippert I; Sequeiros J; Zimmern R; Schmidtke J
    Community Genet; 2008; 11(2):75-120. PubMed ID: 18204250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Misconstructions about health economics applied to prenatal screening].
    Durand-Zaleski I
    Gynecol Obstet Fertil; 2006 Feb; 34(2):89-91. PubMed ID: 16495109
    [No Abstract]   [Full Text] [Related]  

  • 7. Variables that underlie cost efficacy of prenatal screening.
    Kinzler WL; Morrell K; Vintzileos AM
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):277-86, v-vi. PubMed ID: 12108828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of antenatal screening for cystic fibrosis. Couple screening should be preferred for medical reasons.
    Morris J
    BMJ; 1996 Apr; 312(7035):908-9; author reply 910. PubMed ID: 8611894
    [No Abstract]   [Full Text] [Related]  

  • 9. A scientific basis for cost-benefit analysis of genetics services.
    Modell B; Kuliev AM
    Trends Genet; 1993 Feb; 9(2):46-52. PubMed ID: 8456501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.
    Musci TJ; Caughey AB
    Am J Obstet Gynecol; 2005 Jun; 192(6):1905-12; discussion 1912-5. PubMed ID: 15970847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health plans join up for the genomics revolution.
    Carroll J
    Manag Care; 2009 Feb; 18(2):21-2, 24-5. PubMed ID: 19264022
    [No Abstract]   [Full Text] [Related]  

  • 12. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal testing--benefits and costs.
    Scifres CM; Macones GA
    Semin Perinatol; 2008 Aug; 32(4):318-21. PubMed ID: 18652935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should costs and cost-effectiveness be considered in prenatal genetic testing?
    Sparks TN; Caughey AB
    Semin Perinatol; 2018 Aug; 42(5):275-282. PubMed ID: 30173949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health risks, heredity screening and insurance].
    Arnold IJ; van de Vathorst S
    Ned Tijdschr Geneeskd; 1991 Mar; 135(11):480-3. PubMed ID: 2023656
    [No Abstract]   [Full Text] [Related]  

  • 17. The benefits and costs of prenatal diagnosis.
    Chamberlain J
    Rev Epidemiol Sante Publique; 1984; 32(2):85-7. PubMed ID: 6435212
    [No Abstract]   [Full Text] [Related]  

  • 18. Preimplantation genetic screening in older women: a cost-effectiveness analysis.
    Mersereau JE; Plunkett BA; Cedars MI
    Fertil Steril; 2008 Sep; 90(3):592-8. PubMed ID: 18001724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.